Matrix metalloproteinase-β19 expressed in cerebral amyloid angiopathy. (Q53316266)

13 May 2018

title

Matrix metalloproteinase-β19 expressed in cerebral amyloid angiopathy. (English)

1 reference

13 May 2018

author name string

Maarit Tanskanen

1

1 reference

13 May 2018

Liisa Myllykangas

2

1 reference

13 May 2018

Ulpu Saarialho-Kere

3

1 reference

13 May 2018

Anders Paetau

4

1 reference

13 May 2018

publication date

25 January 2011

1 reference

13 May 2018

published in

Amyloid

1 reference

13 May 2018

volume

18

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

3-9

1 reference

13 May 2018

Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Brain parenchymal and microvascular amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Spontaneous brain hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Matrix metalloproteinases and diseases of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Distribution pattern of matrix metalloproteinases 1, 2, 3, and 9, tissue inhibitors of matrix metalloproteinases 1 and 2, and alpha 2-macroglobulin in cases of generalized AA- and AL amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2010.541960

10.3109/13506129.2010.541960

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018